Compare Grab Holdings Ltd. (GRAB) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Grab Holdings Ltd. vs uniQure N.V. Ordinary Shares — how do they compare? Grab Holdings Ltd. trades at $2.9 (market cap $12.19B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: Grab Holdings Ltd. is far larger — about 8.2× uniQure N.V. Ordinary Shares's market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, Grab Holdings Ltd. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Grab Holdings Ltd. for 94 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| GRAB | QURE | |
|---|---|---|
Market Cap | $12.19B | $1.48B |
Volume | 48,418,739 | 2,488,780 |
Sector | Technology | Health |
52-Week High | $6.12 | $70.59 |
52-Week Low | $2.80 | $9.03 |
Typical Hold Time | 94 Days | 0 Days |
Enterprise Value | $7.93B | $728.62M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Grab Holdings trades at $2.98, down 5.4% amid bearish technical signals, though fundamentals show strong improvement with revenue growth to $3.37B in 2025 and a shift to profitability (net income $268M). Recent news highlights a $1.49B acquisition of Atome Financial and insider buying, contrasting with mixed market sentiment.
Outlook is cautiously optimistic: analyst consensus is 91.7% buy ratings, but risks include integration of acquisitions and regional competition. The stock's current price near recent lows may offer entry points for growth-focused investors, pending Q3 2026 earnings results.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Grab Holdings Ltd.
Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.
Read more on GRAB →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
